belimumab

Modify Date: 2024-01-09 10:12:14

belimumab Structure
belimumab structure
Common Name belimumab
CAS Number 356547-88-1 Molecular Weight N/A
Density N/A Boiling Point N/A
Molecular Formula N/A Melting Point N/A
MSDS N/A Flash Point N/A

 Use of belimumab


Belimumab (LymphoStat B) is a human IgG1λ monoclonal antibody that inhibits B-cell activating factor (BAFF). Belimumab can be used for systemic lupus erythematosus (SLE) research[1].

 Names

Name Belimumab

 belimumab Biological Activity

Description Belimumab (LymphoStat B) is a human IgG1λ monoclonal antibody that inhibits B-cell activating factor (BAFF). Belimumab can be used for systemic lupus erythematosus (SLE) research[1].
Related Catalog
References

[1]. Hannah A Blair, et al. Belimumab: A Review in Systemic Lupus Erythematosus. Drugs. 2018 Mar;78(3):355-366.

 Chemical & Physical Properties

No Any Chemical & Physical Properties